Flatbush Diabetes: The Overlooked Form of Diabetes Impacting Black Communities

    Flatbush Diabetes in Blacks

    Diabetes is often framed as either Type 1 or Type 2. But for many patients—particularly in Black communities—that binary framework misses an important and potentially dangerous condition: Flatbush diabetes, also known as ketosis-prone diabetes (KPD).

    First identified in the 1980s among African American patients in the Flatbush neighborhood of Brooklyn, this form of diabetes continues to be under-recognized, even by healthcare professionals.

    What Is Flatbush Diabetes?

    Flatbush diabetes is a hybrid form of diabetes that shares features of both Type 1 and Type 2 diabetes. Like Type 1 diabetes, patients often present suddenly with diabetic ketoacidosis (DKA)—a life-threatening condition.  Like Type 2 diabetes, many patients can eventually come off insulin and maintain control with oral medications or lifestyle changes.

    This dual nature is what makes it dangerous—and frequently misdiagnosed.

    Flatbush diabetes disproportionately affects:

    • African Americans
    • Afro-Caribbean populations
    • Hispanic populations

    It is now recognized globally but remains especially relevant in populations with higher rates of Type 2 diabetes and health disparities.

    For many physicians, this condition represents a critical diagnostic blind spot. They simply don’t think of the diagnosis.

    The Clinical Presentation: A Dangerous First Impression

    Patients with Flatbush diabetes often present with:

    • Very high blood glucose levels
    • Dehydration
    • Nausea, vomiting, abdominal pain
    • Confusion or altered mental status
    • Diabetic ketoacidosis (DKA)

    This presentation mimics classic Type 1 (insulin-dependent) diabetes, leading many doctors to assume lifelong insulin dependence. However, this assumption is often incorrect.

    What Makes Flatbush Diabetes Different?

    Flatbush diabetes has several defining features:

    1. No Autoimmune Destruction

    Unlike Type 1 diabetes, patients lack autoimmune markers such as GAD antibodies.

    2. Reversible Insulin Deficiency

    At diagnosis, insulin production appears severely impaired—but this is often temporary.

    3. Potential for Remission

    With proper treatment:

    • Beta-cell function can recover
    • Insulin may be discontinued within weeks to months
    • Long-term management resembles Type 2 diabetes

    This “reversible phase” is a hallmark of the condition.

    Why Misdiagnosis Happens

    Flatbush diabetes sits in a gray zone:

    FeatureType 1Type 2Flatbush
    DKA at onsetYesRareYes
    AutoantibodiesPresentAbsentAbsent
    Insulin dependenceLifelongSometimesOften temporary

    Because of this overlap, patients are frequently:

    • Misclassified as Type 1
    • Kept on unnecessary lifelong insulin
    • Not counseled on remission potential

    Implications for Black Health

    Flatbush diabetes is more than a clinical curiosity—it is a health equity issue.

    In communities with already high diabetes rates, delayed diagnosis and restricted access to specialty care can result in misdiagnosis.  This leads to:

    • Overtreatment or undertreatment
    • Increased healthcare costs
    • Poorer long-term outcomes

    Recognizing Flatbush diabetes enables precision medicine for populations that need it most.

    Treatment Approach

    Acute Phase (Emergency)

    • Treat DKA aggressively with insulin, fluids, and electrolytes
    • Stabilize the patient (same as Type 1 DKA protocols)
    • Allow a recovery phase
    • Reassess insulin needs frequently
    • Evaluate C-peptide and autoantibodies
    • Gradually taper insulin if appropriate

    Long-Term Management

    • Lifestyle intervention (nutrition, physical activity)
    • Oral agents (e.g., metformin)
    • Ongoing monitoring for relapses

    Many patients achieve insulin independence (go off insulin), though continued follow-up is essential.

    What Clinicians Need to Do Differently

    Think beyond just Type 1 vs. Type 2 tests for autoantibodies and beta-cell function. Reevaluate insulin dependence over time. Educate patients about the possibility of remission.

    Final Thoughts

    Flatbush diabetes challenges our understanding of how to classify diabetes. It reminds us that not all diabetes fits neatly into categories—and failing to recognize that can cost lives. For clinicians serving Black populations, awareness of Flatbush diabetes is not optional—it is essential.

    Dr Greg Hall
    Available on Amazon and other Bookstores

    Related Podcast Episode

  • The Secret to Treating Type 2 Diabetes Without Medicine: We Talk to a Diabetes Educator.

    In this episode:
    Better Black Health welcomes Lewis Bertus, a physician associate and diabetes educator, specializing in the couseling of people who want to reverse their diabetes diagnosis. We discuss the diet changes needed as well as other approaches to not let diabetes…
    Play Episode
  • Dr Greg Hall

    Greg Hall, MD is a physician, author, speaker, inventor, professor, and public health professional, specializing in urban health and the clinical care of African Americans. Dr. Hall’s extensive research in the care of African Americans lead to the development of GNetX Sequence Multivitamins a supplement developed to support African American needs. Most recently, Dr. Hall established the National Institute for African American Health, which is a nonprofit designed to promote health-related education, support students interested in a career in medicine, and serve as an advocate for African American patients. You can keep in touch with Dr. Hall by tuning into his Better Black Health Podcast where he covers Black American health topics.

    Further Reading Recommendations

    Prefer to listen? Check out these podcast episodes!